Ignite Creation Date:
2024-05-06 @ 5:44 PM
Last Modification Date:
2024-10-26 @ 2:34 PM
Study NCT ID:
NCT05415969
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2022-06-01
Brief Title:
CKD-aP Among Adults on Dialysis in Switzerland
Sponsor:
University of Applied Sciences of Western Switzerland
Organization:
University of Applied Sciences of Western Switzerland
Study Overview
Official Title:
Uremic Pruritus Among Adults on Dialysis in the French Speaking Part of Switzerland
Status:
COMPLETED
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
UP-RAISE
Brief Summary:
Chronic Kidney Disease Associated Pruritus CKD-aP represents a localized or a generalized skin itch which is a common symptom occurring in end-stage renal disease and dialysis The prevalence of CKD-aP in adults on dialysis varies between countries ranging between 20-42 Swiss data on CKD-aP are unfortunately largely lacking as Switzerland is so far not part of large registries such as DOPPS
The aging population the increase in diabetes 69 by 2030 the increase in hypertension 60 by 2025 and poly-morbidity will probably lead to a rise in the number of patients on dialysis and subsequent CKD-aP
CKD-aP is associated with sleep disturbances compromised quality of life emotional distress and increased risks of hospitalization and death Its management lacks approaches that are supported by strong evidence because its pathogenesis remains poorly understood and may be related to an increase in uremic toxins skin inflammation In this context sweat composition deserves more attention
Aim of the study The aim of the study is to determine the prevalence of CKD-aP in the population on dialysis the association between CKD-aP and different electrolytes and the potential role of the composition of sweat in CKD-aP
Results will be used for building a CKD-aP symptom management program to improve the quality of care of patients on dialysis and will be incorporated in the nursing continuing education program
The aging population the increase in diabetes 69 by 2030 the increase in hypertension 60 by 2025 and poly-morbidity will probably lead to a rise in the number of patients on dialysis and subsequent CKD-aP
CKD-aP is associated with sleep disturbances compromised quality of life emotional distress and increased risks of hospitalization and death Its management lacks approaches that are supported by strong evidence because its pathogenesis remains poorly understood and may be related to an increase in uremic toxins skin inflammation In this context sweat composition deserves more attention
Aim of the study The aim of the study is to determine the prevalence of CKD-aP in the population on dialysis the association between CKD-aP and different electrolytes and the potential role of the composition of sweat in CKD-aP
Results will be used for building a CKD-aP symptom management program to improve the quality of care of patients on dialysis and will be incorporated in the nursing continuing education program
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None